|
HJURP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.29030000029351E-07 |
| Normal-vs-Stage2 |
1.489790E-02 |
| Normal-vs-Stage3 |
7.55390000000133E-05 |
| Normal-vs-Stage4 |
2.038400E-02 |
| Stage1-vs-Stage2 |
6.193800E-01 |
| Stage1-vs-Stage3 |
1.664810E-03 |
| Stage1-vs-Stage4 |
5.862000E-02 |
| Stage2-vs-Stage3 |
6.696600E-03 |
| Stage2-vs-Stage4 |
8.232500E-02 |
| Stage3-vs-Stage4 |
8.175000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.82083253924748E-12 |
| Normal-vs-AfricanAmerican |
2.3959999999601E-06 |
| Normal-vs-Asian |
5.820200E-02 |
| Caucasian-vs-AfricanAmerican |
4.452000E-01 |
| Caucasian-vs-Asian |
1.719360E-01 |
| AfricanAmerican-vs-Asian |
3.510300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.56759108103233E-13 |
| Normal-vs-Female |
1.64010000003323E-06 |
| Male-vs-Female |
7.750400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.808000E-04 |
| Normal-vs-Extreme_Weight |
1.60379998170868E-09 |
| Normal-vs-Obese |
5.51639999999409E-05 |
| Normal-vs-Extreme_Obese |
2.279900E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.196300E-02 |
| Normal_Weight-vs-Obese |
8.685800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.137500E-03 |
| Extreme_Weight-vs-Obese |
4.307600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.767600E-04 |
| Obese-vs-Extreme_Obese |
9.620400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.803650E-03 |
| Normal-vs-Age(41-60Yrs) |
8.0323999673837E-09 |
| Normal-vs-Age(61-80Yrs) |
3.56849999993969E-07 |
| Normal-vs-Age(81-100Yrs) |
6.619900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.048190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.121900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.466140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.659600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.823800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.677400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62525548574877E-12 |
| Normal-VS-Type2 PRCC |
4.7521999999578E-06 |
| Normal-VS-KIRP CIMP |
1.740240E-03 |
| Normal-VS-Unclassified PRCC |
7.018000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.011900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.480400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.448780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.059200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.107000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.360900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1646999999978E-05 |
| Normal-vs-N1 |
1.73211999999756E-05 |
| Normal-vs-N2 |
4.829900E-02 |
| N0-vs-N1 |
4.358700E-04 |
| N0-vs-N2 |
2.265200E-01 |
| N1-vs-N2 |
2.534000E-01 |
|
|
